Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-14 Exercise | 2026-02-18 5:05 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Mahaney Paige Chief Scientific Officer | 7,050 | $0 | 336,910 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-18 5:05 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Mahaney Paige Chief Scientific Officer | 2,446 | $1.89 | 336,910 (Direct) | View |
| 2026-02-13 Option Award | 2026-02-18 5:05 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Mahaney Paige Chief Scientific Officer | 240,000 | $0 | 336,910 (Direct) | View |
| 2025-10-28 Tax Withholding | 2025-10-30 4:30 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Mahaney Paige Chief Scientific Officer | 5,644 | $2.58 | 99,356 (Direct) | View |
| 2025-10-28 Exercise | 2025-10-30 4:30 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Mahaney Paige Chief Scientific Officer | 19,200 | $0 | 99,356 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-18 4:54 pm | N/A 2035-02-13 | C4 Therapeutics Inc. | CCCC | Mahaney Paige Chief Scientific Officer | 70,600 | $0 | 147,400 (Direct) | View |
| 2024-10-28 Option Award | 2024-10-29 4:31 pm | N/A 2034-10-27 | C4 Therapeutics Inc. | CCCC | Mahaney Paige Chief Scientific Officer | 422,400 | $0 | 422,400 (Direct) | View |